
Zapoznaj się z urządzeniami : Seegene NIMBUS, Seegene STARlet i Seegene STARlet-AIOS™

Ponad 160 publikacji naukowych potwierdzających wysoką jakość testów HPV Seegene, w tym:
Oštrbenk Valenčak A, Cuschieri K, Connor L, Zore A, Smrkolj Š, Poljak M. Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening. J Clin Virol. 2024;170:105638. doi:10.1016/j.jcv.2023.105638
Chung PYJ, Dhillon SK, Cortoos S, et al. Evaluation of the Allplex HPV assay’s adherence to international guidelines for cervical cancer screening in clinician-collected samples. Microbiol Spectr. 2024;12(8):e0033224. doi:10.1128/spectrum.00332-24
Arroyo Mühr LS, Eklund C, Lagheden C, et al. Continuous Global Improvement of Human Papillomavirus (HPV) Genotyping Services: The 2022 and 2023 HPV LabNet International Proficiency Studies. J Med Virol. 2024;96(10):e70022. doi:10.1002/jmv.70022
Bell M, Verberckmoes B, Devolder J, et al. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples. Microbiol Spectr. 2023;11(4):e0008123. doi:10.1128/spectrum.00081-23
© 2026 Newlab, All rights reserved
Projekt i realizacja: WeAreCreative